Disseminating science-based prevention: Lessons learned from CSAP's CAPTs

Journal of Drug Education

Volumn 33, Issue 3, 2003, Pages 233-243

  Hogan, Julie A ^a,h   Baca, Ileana ^b   Daley, Charlotte ^c   Garcia, Tania ^d   Jaker, Jerry ^e   Lowther, Mike ^f   Kutzner, Michael ^g  

^a CSAP's Western CAPT   (United States)

^b CSAP's Border CAPT   (United States)

^c CSAP's Southeast CAPT   (United States)

^d CSAP's Northeast CAPT   (United States)

^e CSAP's Central CAPT   (United States)

^f CSAP's Southwest CAPT   (United States)

^g The CDM Group Inc   (United States)

^h UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTER FOR SUBSTANCE ABUSE PREVENTION; CENTER FOR THE APPLICATION OF PREVENTION TECHNOLOGIES; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; REVIEW; SCIENCE; SUBSTANCE ABUSE; TECHNOLOGY;

DIFFUSION OF INNOVATION; HEALTH POLICY; HEALTH PROMOTION; HUMANS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; UNITED STATES SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION;

EID: 1442335028     PISSN: 00472379     EISSN: None     Source Type: Journal    
DOI: 10.2190/DWMW-0T6T-61N1-GB7X     Document Type: Review

References (22)

1. C. LaFond, T. L. Toomey, C. Rothstein, W. Manning, and A. C. Wagenaar, Policy Evaluation Research: Measuring the Independent Variables, Evaluation Review, 24:1, pp. 92-101, 2000.
2. A. C. Wagenaar, E. M. Harwood, T. L. Toomey, C. E. Denk, and K. M. Zander, Public Opinion on Alcohol Policies in the United States: Results from a National Survey, Journal of Public Health Policy, 21:3, pp. 303-327, 2000.
3. D. M. Gorman, The Irrelevance of Evidence in the Development of School-Based Drug Prevention Policy, 1986-1996, in Zero Effects of Drug Prevention Programs: Issues and Solutions, I. G. G. Kreft and J. H. Brown (eds.), Evaluation Review, 22:1, pp. 118-146, Sage Periodicals Press, Thousand Oaks, California, 1998.
4. D. M. Gorman, The Irrelevance of Evidence in the Development of School-Based Drug Prevention Policy, 1986-1996, in Zero Effects of Drug Prevention Programs: Issues and Solutions, I. G. G. Kreft and J. H. Brown (eds.), Evaluation Review, 22:1, pp. 118-146, Sage Periodicals Press, Thousand Oaks, California, 1998.
5. R. B. Haynes, Some Problems in Applying Evidence in Clinical Practice, Annals of the New York Academy of Sciences, 703, pp. 210-224, 1993.
6. E. M. Rogers, Diffusion of Innovations (4th Edition), Free Press, New York, 1995.
7. W. McGuire, Attitudes and Attitude Change, in The Handbook of Social Psychology (3rd Edition), G. Lindzey and E. Arsonson (eds.), Random House, New York, 1985.
8. L. Wallack, Media Advocacy and Social Marketing Approaches, in Mass Communication and Public Health, C. Atkin and L. Wallack (eds.), Sage Publications, Newbury Park, New Jersey, 1990.
9. A. G. Ellrodt, L. Conner, M. Riedinger, and S. Weingarten, Measuring and Improving Physician Compliance with Clinical Practice Guidelines, A Controlled Interventional Trial, Annals of Internal Medicine, 122, pp. 277-282, 1995.
10. G. Laffel and D. Blumenthal, The Case of Using Industrial Quality Management Science in Health Care Organizations, Journal of the American Medical Association, 262:20, pp. 2869-2873, 1989.
11. T. E. Backer, Drug Abuse Technology Transfer, (DHHS Publication No. ADM 91-1764), National Institute of Drug Abuse, Rockville, Maryland, 1991.
12. T. E. Backer, Knowledge Utilization: The Third Wave, Knowledge: Creation, Diffusion, Utilization, 12, pp. 225-240, 1991.
13. D. A. Davis and A. Taylor-Vaisey, Translating Guidelines into Practice: A Systematic Review of Theoretic Concepts, Practical Experience and Research Evidence in the Adoption of Clinical Practice Guidelines, Canadian Medical Association Journal, 157, pp. 408-416, 1997.
14. R. D. Walker, M. O. Howard, M. D. Lambert, and R. Suchinsky, Medical Practice Guidelines, Western Journal of Medicine, 161, pp. 39-44, 1994.
15. A. Nardella, L. Pechet, and L. M. Snyder, Continuous Improvement, Quality Control, and Cost Containment in Clinical Laboratory Testing. Effects of Establishing and Implementing Guidelines for Preoperative Tests, Archives Pathology and Laboratory Medicine, 119:6, pp. 518-522, 1995.
16. C. Atkin and E. B. Arkin, Issues in Communicating Health Information, in C. Atkin and L. Wallack (eds.), Mass Communication and Public Health, Sage Publications, Newbury Park, New Jersey, 1990.
17. C. R. Horowitz, H. I. Goldberg, D. P. Martin, E. H. Wagner, S. D. Fihn, D. B. Christensen, and A. D. Cheadle, Conducting a Randomized Controlled Trial of CQI and Academic Detailing to Implement Clinical Guidelines, The Joint Commission Journal on Quality Improvement, 22, pp. 734-750, 1996.
18. A. Greer, The Two Cultures of Biomedicine: Can There be Consensus? Journal of the American Medical Association, 258:1, pp. 2739-2740, 1987.
19. National Institute on Alcohol Abuse and Alcoholism, Keeping Kids Alcohol Free: Strategies for Action, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland, 2001.
20. D. J. Cook, N. L. Greengold, A. G. Ellrodt, and S. R. Weingarten, The Relation between Systematic Reviews and Practice Guidelines, Annals of Internal Medicine, 127, pp. 210-216, 1997.
21. M. D. Klitzner, A Public Health/Dynamic Systems Approach to Community-Wide Alcohol and Other Drug Initiatives, in Drugs and the Community: Involving Community Residents in Combating the Sale of Illegal Drugs, R. C. Davis, A. J. Lurigio, and D. P. Rosenbaum (eds.), Charles C. Thomas, Springfield, Illinois, 1993.
22. H. D. Holder, Community Responses, in Prevention and Societal Impact of Drug and Alcohol Abuse, R. T. Ammerman, P. J. Ott, and R. E. Tarter (eds.), Lawrence Erlbaum Associates, Mahwah, New Jersey, 1999.